Search research articles
Contact Us
Filters
Showing results (531-540 of 596) with videos related to
Page
of 60
Sort By:
Journal of the American College of Cardiology
|
December 10, 2013
Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)
Shaun G Goodman, Daniel M Wojdyla, Jonathan P Piccini, et al.
JACC. Heart Failure
|
June 15, 2020
Splanchnic Nerve Block for Chronic Heart Failure
Marat Fudim, Richard L Boortz-Marx, Arun Ganesh, et al.
NEJM Evidence
|
May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation
Satoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Journal of the American Heart Association
|
January 22, 2019
Emergency Consent: Patients' and Surrogates' Perspectives on Consent for Clinical Trials in Acute Stroke and Myocardial Infarction
Neal W Dickert, Victoria M Scicluna, Opeolu Adeoye, et al.
Journal of the American College of Cardiology
|
July 30, 2016
1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study
Pamela S Douglas, Bernard De Bruyne, Gianluca Pontone, et al.
European Heart Journal
|
September 3, 2015
Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study
Pamela S Douglas, Gianluca Pontone, Mark A Hlatky, et al.
The New England Journal of Medicine
|
March 17, 2015
Outcomes of anatomical versus functional testing for coronary artery disease
Pamela S Douglas, Udo Hoffmann, Manesh R Patel, et al.
American Heart Journal
|
May 25, 2024
Framework of the strengths and challenges of clinically integrated trials: An expert panel report
Anthony E Peters, W Schuyler Jones, Brian Anderson, et al.
The Lancet. Neurology
|
March 10, 2012
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
Graeme J Hankey, Manesh R Patel, Susanna R Stevens, et al.
JAMA Network Open
|
July 23, 2021
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials
Akash Goyal, Tony Schibler, Brooke Alhanti, et al.
Page
of 60
Search research articles
Search
Showing results (531-540 of 596) with videos related to
Sort By:
Page
of 60
Journal of the American College of Cardiology
|
December 10, 2013
Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)
Shaun G Goodman, Daniel M Wojdyla, Jonathan P Piccini, et al.
JACC. Heart Failure
|
June 15, 2020
Splanchnic Nerve Block for Chronic Heart Failure
Marat Fudim, Richard L Boortz-Marx, Arun Ganesh, et al.
NEJM Evidence
|
May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation
Satoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Journal of the American Heart Association
|
January 22, 2019
Emergency Consent: Patients' and Surrogates' Perspectives on Consent for Clinical Trials in Acute Stroke and Myocardial Infarction
Neal W Dickert, Victoria M Scicluna, Opeolu Adeoye, et al.
Journal of the American College of Cardiology
|
July 30, 2016
1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study
Pamela S Douglas, Bernard De Bruyne, Gianluca Pontone, et al.
European Heart Journal
|
September 3, 2015
Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study
Pamela S Douglas, Gianluca Pontone, Mark A Hlatky, et al.
The New England Journal of Medicine
|
March 17, 2015
Outcomes of anatomical versus functional testing for coronary artery disease
Pamela S Douglas, Udo Hoffmann, Manesh R Patel, et al.
American Heart Journal
|
May 25, 2024
Framework of the strengths and challenges of clinically integrated trials: An expert panel report
Anthony E Peters, W Schuyler Jones, Brian Anderson, et al.
The Lancet. Neurology
|
March 10, 2012
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
Graeme J Hankey, Manesh R Patel, Susanna R Stevens, et al.
JAMA Network Open
|
July 23, 2021
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials
Akash Goyal, Tony Schibler, Brooke Alhanti, et al.
Page
of 60